Abstract
Various bio-medical applications of magnetic nanoparticles have been explored during the past few decades. As tools that hold great potential for advancing biological sciences, magnetic nanoparticles have been used as platform materials for enhanced magnetic resonance imaging (MRI) agents, biological separation and magnetic drug delivery systems, and magnetic hyperthermia treatment. Furthermore, approaches that integrate various imaging and bioactive moieties have been used in the design of multi-modality systems, which possess synergistically enhanced properties such as better imaging resolution and sensitivity, molecular recognition capabilities, stimulus responsive drug delivery with on-demand control, and spatio-temporally controlled cell signal activation. Below, recent studies that focus on the design and synthesis of multi-mode magnetic nanoparticles will be briefly reviewed and their potential applications in the imaging and therapy areas will be also discussed.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Alivisatos, A.P. (1996). Perspectives on the physical chemistry of semiconductor nanocrystals. J. Phys. Chem. 100, 13226–3239.
Apple, F.S. (2011). Biomarkers in aggregate. Nat. Biotechnol. 29, 236–237.
Arbab, A.S., Liu, W., and Frank, J.A. (2006). Cellular magnetic resonance imaging: current status and future prospects. Expert Rev. Med. Devices 3, 427–439.
Bedja, I., Hotchandani, S., and Kamat, P.V. (1994). Preparation and photoelectrochemical characterization of thin SnO2 nanocrystalline semiconductor films and their sensitization with bis(2,2′-bipyridine)(2,2′-bipyridine-4,4′-dicarboxylic acid)ruthenium(ii) complex. J. Phys. Chem. 98, 4133–4140.
Bigioni, TP., Lin, XM., Nguyen, TT., Corwin, EI., Witten, TA., and Jaeger, H.M. (2006). Kinetically driven self assembly of highly ordered nanoparticle monolayers. Nat. Mater. 5, 265–270.
Bonitatibus, P.J. Jr., Torres, A.S., Goddard, G.D., FitzGerald, P.F., and Kulkarni, A.M. (2010). Synthesis, characterization, and computed tomography imaging of a tantalum oxide nanoparticle imaging agent. Chem. Commun. 46, 8956–8958.
Cheon, J., and Lee, J.H. (2008). Synergistically integrated nanoparticles as multimodal probes for nanobiotechnology. Acc. Chem. Res. 41, 1630–1640.
Choi, J.S., Choi, H.J., Jung, D.C., Lee, J.H., and Cheon, J. (2008a). Nanoparticle assisted magnetic resonance imaging of the early reversible stages of amyloid beta self-assembly. Chem. Commun. 2197–2199.
Choi, J.S., Park, J.C., Nah, H., Woo, S., Oh, J., Kim, K.M., Cheon, G.J., Chang, Y., Yoo, J., and Cheon, J. (2008b). A hybrid nanoparticle probe for dual-modality positron emission tomography and magnetic resonance imaging. Angew. Chem. Int. Ed. Engl. 47, 6259–6262.
Choi, J.Y., Lee, S.H., Na, H.B., An, K., Hyeon, T., and Seo, T.S. (2010a). In vitro cytotoxicity screening of water-dispersible metal oxide nanoparticles in human cell lines. Bioprocess Biosyst. Eng. 33, 21–30.
Choi, J.S., Lee, J.H., Shin, T.H., Song, H.T., Kim, E.Y., and Cheon, J. (2010b). Self-confirming “AND” logic nanoparticles for faultfree MRI. J. Am. Chem. Soc. 132, 11015–11017.
Crick, F.H.C., and Hughes, A.F.W. (1950). The physical properties of cytoplasm — a study by means of the magnetic particle method.1. experimental. Exp. Cell Res. 1, 37–80.
Cullity, B.D. (1972). Introduction to Magnetic Materials (Addison-Wesley Publishing: Reading).
Dabbousi, B., RodriguezViejo, J., Mikulec, F., Heine, J., Mattoussi, H., Ober, R., Jensen, K., and Bawendi, M.G. (1997). (CdSe)ZnS core-shell quantum dots: synthesis and characterization of a size series of highly luminescent nanocrystallites. J. Phys. Chem. B 101, 9463–9475.
Derfus, A.M., von Maltzahn, G., Harris, T.J., Duza, T., Vecchio, K.S., Ruoslahti, E., and Bhatia, S.N. (2007). Remotely triggered release from magnetic nanoparticles. Adv. Mater. 19, 3932–3936
Dobson, J. (2006). Magnetic nanoparticles for drug delivery. Drug Dev. Res. 67, 55–60.
Ferrari, M. (2005). Cancer nanotechnology: opportunities and challenges. Nat. Rev. Cancer 5, 161–171.
Fortin, J.P., Wilhelm, C., Servais, J., Menager, C., Bacri, J.C., and Gazeau, F. (2007). Size-sorted anionic iron oxide nanomagnets as colloidal mediators for magnetic hyperthermia. J. Am. Chem. Soc. 129, 2628–2635.
Ghadiali, J.E., and Stevens, M.M. (2008). Enzyme-responsive nanoparticle systems. Adv. Mater. 20, 4359–4363.
Giri, S., Trewyn, B.G., Stellmaker, M.P., and Lin, V.S.-Y. (2005). Stimuli-responsive controlled-release delivery system based on mesoporous silica nanorods capped with magnetic nanoparticles. Angew. Chem. Int. Ed. Engl. 44, 5038–5044.
Glogauer, M., Ferrier, J.C., and McCulloch, A. (1995). Magneticfields applied to collagen-coated ferric-oxide beads induce stretch-activated ca2+ flux in fibroblasts. Am. J. Physiol. Cell Physiol. 269, 1093–1104.
Gupta, A.K., and Gupta, M. (2005). Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 26, 3995–4021.
Harmon, B.V., Corder, A.M., Collins, R.J., Gob, G.C., Allen, J., Allan, D.J., and Kerr, J.F. (1990). Cell-death induced in a murine mastocytoma by 42–47-degrees-c heating in vitro — evidence that the form of death changes from apoptosis to necrosis above a critical heat load. Int. J. Radiat. Biol. 58, 845–858.
Harris, T.J., von Maltzahn, G., Derfus, A.M., Ruoslahti, E., and Bhatia, S.N. (2006). Proteolytic actuation of nanoparticle selfassembly. Angew. Chem. Int. Ed. Engl. 45, 3161–3165.
Henze, M., Schuhmacher, J., Hipp, P., Kowalski, J., Becker, D.W., Doll, J., Mäcke, H.R., Hofmann, M., Debus, J., and Haberkorn, U.J. (2001). PPET imaging of somatostatin receptors using [(68)GA] DOTA-D-Phe(1)-Tyr(3)-octreotide: First results in patients with meningiomas. J. Nucl. Med. 42, 1053–1056.
Hergt, R., Andra, W., d’Ambly, C.G., Hilger, I., Kaiser, W.A., Richter, U., and Schmidt, H.G. (1998). Physical limits of hyperthermia using magnetite fine particles. IEEE Trans. Magn. 34, 3745–3754.
Hergt, R., Dutz, S., Muller, R., and Zeisberger, M. (2006). Magnetic particle hyperthermia: nanoparticle magnetism and materials development for cancer therapy. J. Phys. Condens. Matter. 18, 2919–2934.
Hong, R., Fischer, N.O., Emrick, T., and Rotello, V.M. (2005). Surface PEGylation and ligand exchange chemistry of FePt nanoparticles for biological applications. Chem. Mater. 17, 4617–4621.
Hyeon, T. (2003). Chemical synthesis of magnetic nanoparticles. Chem. Commun. 927–934.
Jana, N.R., Chen, Y., and Peng, X. (2004). Size- and shape-controlled magnetic (Cr, Mn, Fe, Co, Ni) oxide nanocrystals via a simple and general approach. Chem. Mater. 16, 3931–3935.
Judenhofer, M.S., Wehrl, H.F., Newport, D.F., Catana, C., Siegel, S.B., Becker, M., Thielscher, A., Kneilling, M., Lichy, M.P., Eichner, M., et al. (2008). Simultaneous PET-MRI: a new approach for functional and morphological imaging. Nat. Med. 14, 459–465.
Jun, Y.W., Huh, Y.M., Choi, J.S., Lee, J.H., Song, H.T., Kim, S., Yoon, S., Kim, K.S., Shin, J.S., Suh, J.S., et al. (2005). Nanoscale size effect of nanocrystals and their utilization for cancer diagnosis via magnetic resonance imaging (MRI). J. Am. Chem. Soc. 127, 5732–5733.
Jun, Y.W., Choi, J., and Cheon, J. (2007). Heterostructured magnetic nanoparticles: their versatility and high performance capabilities. Chem. Commun. 1203–1214.
Jun, Y.W., Seo, J.W., and Cheon, J. (2008a). Nanoscaling laws of magnetic nanoparticles and their applicabilities in biomedical sciences. Acc. Chem. Res. 41, 179–189.
Jun, Y.W., Lee, J.H., and Cheon, J. (2008b). Chemical design of nanoparticle probes for high-performance magnetic resonance imaging. Angew. Chem. Int. Ed. Engl. 47, 5122–5135.
Jung, C.W., and Jacobs, P. (1995). Physical and chemical-properties of superparamagnetic iron-oxide MR contrast agents — ferumoxides, ferumoxtran, ferumoxsil. Magn. Reson. Imaging 13, 661–674.
Kelly, K.L., Coronado, E., Zhao, L.L., and Schatz, G.C. (2003). The optical properties of metal nanoparticles: the influence of size, shape, and dielectric environment. J. Phys. Chem. B 107, 668–677.
Kim, J., Piao, Y., and Hyeon, T. (2009). Multifunctional nanostructured materials for multimodal imaging, and simultaneous imaging and therapy. Chem. Soc. Rev. 38, 372–390.
Kubaska, S., Sahani, D.V., Saini, S., Hahn, P.F., and Halpern, E. (2001). Dual contrast enhanced magnetic resonance imaging of the liver with superparamagnetic iron oxide followed by gadolinium for lesion detection and characterization. Clin. Radiol. 56, 410–415.
Lai, C.Y., Trewyn, B.G., Jeftinija, D.M., Jeftinija, K., Xu, S., Jeftinija, S., and Lin, V.S. (2003). A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules. J. Am. Chem. Soc. 125, 4451–4459.
Latham, A.H., and Williams, M.E. (2006). Versatile routes toward functional, water-soluble nanoparticles via trifluoroethylester-PEG-thiol ligands. Langmuir 22, 4319–4326.
Latham, A.H., and Williams, M.E. (2008). Controlling transport and chemical functionality of magnetic nanoparticles. Acc. Chem. Res. 41, 411–420.
Lauffer, R.E. (1987). Paramagnetic metal-complexes as water proton relaxation agents for nmr imaging — theory and design. Chem. Rev. 87, 901–927.
Lee, J.H., Jun, Y.W., Yeon, S.I., Shin, J.S., and Cheon, J. (2006). Dual-mode nanoparticle probes for high-performance magnetic resonance and fluorescence imaging of neuroblastoma. Angew. Chem. Int. Ed. Engl. 118, 8340–8342.
Lee, J.H., Huh, Y.M., Jun, Y.W., Seo, J.W., Jang, J.T., Song, H.T., Kim, S., Cho, E.J., Yoon, H.G., Suh, J.S., et al. (2007). Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging. Nat. Med. 13, 95–99.
Lee, J.H., Lee, K., Moon, S.H., Lee, Y., Park, T.G., and Cheon, J. (2009). All-in-one target-cell-specific magnetic nanoparticles for simultaneous molecular imaging and siRNA delivery. Angew. Chem. Int. Ed. Engl. 121, 4238–4243.
Lee, J.E., Lee, N., Kim, H., Kim, J., Choi, S.H., Kim, J.H., Kim, T., Song, I.C., Park, S.P., Moon, W.K., et al. (2010). Uniform mesoporous dye-doped silica nanoparticles decorated with multiple magnetite nanocrystals for simultaneous enhanced magnetic resonance imaging, fluorescence imaging, and drug delivery. J. Am. Chem. Soc. 132, 552–557.
Lee, J.H., Jang, J.T., Choi, J.S., Moon, S.H., Noh, S.H., Kim, J.W., Kim, J.G., Kim, I.S., Park, K.I., and Cheon, J. (2011). Exchangecoupled magnetic nanoparticles for efficient heat induction. Nat. Nanotechnol. 6, 418–422.
Lee, N., Cho, H.R., Oh, M.H., Lee, S.H., Kim, K., Kim, B.H., Shin, K., Ahn, T.Y., Choi, J.W., Kim, Y.W., et al. (2012). Multifunctional Fe3O4/TaOx core/shell nanoparticles for simultaneous magnetic resonance imaging and X-ray computed tomography. J. Am. Chem. Soc. 134, 10309–10312.
Lewin, M., Carlesso, N., Tung, C.H., Tang, X.W., Cory, D., Scadden, D.T., and Weissleder, R. (2000). Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat. Biotechnol. 18, 410–414.
Ling, Y., Pong, T., Vassiliou, C.C., Huang, P.L., and Cima, M.J. (2011). Implantable magnetic relaxation sensors measure cumulative exposure to cardiac biomarkers. Nat. Biotechnol. 29, 273–278.
Link, S., and El-Sayed, M.A. (1999). Spectral properties and relaxation dynamics of surface plasmon electronic oscillations in gold and silver nanodots and nanorods. J. Phys. Chem. B. 103, 8410–8426.
Liu, T.Y., Hu, S.H., Liu, D.M., Chen, S.Y., and Chen, I.W. (2009). Biomedical nanoparticle carriers with combined thermal and magnetic responses. Nano Today 4, 52–65.
Maccioni, F., Bruni, A., Viscido, A., Colaiacomo, M.C., Cocco, A., Montesani, C., Caprilli, R., and Marini, M. (2006). MR imaging in patents with Crohn disease: Value of T2-versus T1-weighted gadolinium-enhanced MR sequences with use of an oral superparamagnetic contrast agent. Radiology 238, 517–530.
Maier-Hauff, K., Ulrich, F., Nestler, D., Niehoff, H., Wust, P., Thiesen, B., Orawa, H., Budach, V., and Jordan, A. (2011). Efficacy and safety of intratumoral thermotherapy using magnetic ironoxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme. J. Neurooncol. 103, 317–324.
Massoud, T.F., and Gambhir, S.S. (2003). Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev. 17, 545–580.
Medarova, Z., Pham, W., Farrar, C., Petkova, V., and Moore, A. (2007). In vivo imaging of siRNA delivery and silencing in tumors. Nat. Med. 13, 372–377.
Molday, R.S. (1984). US patent 4, 452, 773.
Moser, A., Takano, K., Margulies, D.T., Albrecht, M., Sonobe, Y., Ikeda, Y., Sun, S.H., and Fullerton, E.E. (2002). Magnetic recording: advancing into the future. J. Phys. D Appl. Phys. 35, 157–167.
Murray, C.B., Sun, S.H., Doyle, H., and Betley, T. (2001). Monodisperse 3d transition-metal (Co, Ni, Fe) nanoparticles and their assembly into nanoparticle superlattices. MRS Bull. 26, 985–991.
Na, H.B., Song, I.C., and Hyeon, T. (2009). Inorganic nanoparticles for MRI contrast agents. Adv. Mater. 21, 2133–2148.
Neuberger, T., Schopf, B., Hofmann, H., Hofmann, M., and von Rechenberg, B. (2005). Superparamagnetic nanoparticles for biomedical applications: possibilities and limitations of a new drug delivery system. J. Magn. Magn. Mater. 293, 483–496.
Noh, S.H., Na, W., Jang, J.T., Lee, J.H., Lee, E.J., Moon, S.H., Lim, Y., Shin, J.S., and Cheon, J. (2012). Nanoscale magnetism control via surface and exchange anisotropy for optimized ferrimagnetic hysteresis. Nano Lett. 12, 3716–3721.
Ntziachristos, V., Yodh, A.G., Schnall, M., and Chance, B. (2000). Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement. Proc. Natl. Acad. Sci. USA 97, 2767–2722.
Oh, M.H., Lee, N., Kim, H., Park, S.P., Piao, Y., Lee, J., Jun, S.W., Moon, W.K., Choi, S.H., and Hyeon, T. (2011). Large-scale synthesis of bioinert tantalum oxide nanoparticles for X-ray computed tomography imaging and bimodal image-guided sentinel lymph node mapping. J. Am. Chem. Soc. 133, 5508–5515.
O’Neill, K.L., Fairbairn, D.W., Smith, M.J., and Poe, B.S. (1998). Critical parameters influencing hyperthermia-induced apoptosis in human lymphoid cell lines. Apoptosis 3, 369–375.
Ow, H., Larson, D.R., Srivastava, M., Baird, B.A., Webb, W.W., and Wiesner, U. (2005). Bright and stable core-shell fluorescent silica nanoparticles. Nano Lett. 5, 113–117.
Pankhurst, Q.A., Connolly, J., Jones, S.K., and Dobson, J. (2003). Applications of magnetic nanoparticles in biomedicine. J. Phys. D Appl. Phys. 36, 167–181.
Pannaparayil, T., and Komarneni, S. (1989). Synthesis and characterization of ultrafine cobalt ferrites. IEEE Trans. Magn. 25, 4233–4235.
Peer, D., Karp, J.M., Hong, S., FaroKHzad, O.C., Margalit, R., and Langer, R. (2007). Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotech. 2, 751–760.
Peng, S., Wang, C., Xie, J., and Sun, S. (2006). Synthesis and stabilization of monodisperse Fe nanoparticles. J. Am. Chem. Soc. 128, 10676–10677.
Perez, J.M., O’Loughin, T., Simeone, F.J., Weissleder, R., and Josephson, L. (2002a). DNA-based magnetic nanoparticle assembly acts as a magnetic relaxation nanoswitch allowing screening of DNA-cleaving agents. J. Am. Chem. Soc. 124, 2856–2857.
Perez, J.M., Josephson, L., O’Loughlin, T., Högemann, D., and Weissleder, R. (2002b). Magnetic relaxation switches capable of sensing molecular interactions. Nat. Biotechnol. 20, 816–820.
Prodan, E., Radloff, C., Halas, N.J., and Nordlander, P. (2003). A hybridization model for the plasmon response of complex nanostructures. Science 302, 419–422.
Reimer, P., and Balzer, T. (2003). Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrastenhanced MRI of the liver: properties, clinical development, and applications. Eur. Radiol. 13, 1266–1276.
Reimer, P., Rummeny, E.J., Daldrup, H.E., Balzer, T., Tombach, B., Berns, T., and Peters, P.E. (1995). Clinical-result with resovist — A phase-2 clinical-trail. Radiology 195, 489–496.
Rodriguez, O., Fricke, S., Chien, C., Dettin, L., VanMeter, J., Shapiro, E., Dai, H.N., Casimiro, M., Ileva, L., Dagata, J., et al. (2006). Contrast-enhanced in vivo imaging of breast and prostate cancer cells by MRI. Cell Cycle 5, 113–119.
Sarikaya, M., Tamerler, C., Jen, A., Schulten, K., and Baneyx, F. (2003). Molecular biomimetics: nanotechnology through biology. Nat. Mater. 2, 577–585.
Smith, A.M., and Nie, S. (2010). Semiconductor nanocrystals: structure, properties, and band gap engineering. Acc. Chem. Res. 43, 190–200.
Sun, S.H. (2006). Recent advances in chemical synthesis, selfassembly, and applications of FePt nanoparticles. Adv. Mater. 18, 393–403.
Sun, S.H., Zeng, H., Robinson, D.B., Raoux, S., Rice, P.M., Wang, S.X., and Li, G.X. (2004). Monodisperse MFe2O4 (M = Fe, Co, Mn) nanoparticles. J. Am. Chem. Soc. 126, 273–279.
Thomas, C.R., Ferris, D.P., Lee, J.H., Choi, E., Cho, M.H., Kim, E.S., Stoddart, J.F., Shin, J.S., Cheon, J., and Zink, J.I. (2010). Noninvasive remote-controlled release of drug molecules in vitro using magnetic actuation of mechanized nanoparticles. J. Am. Chem. Soc. 132, 10623–10625.
Tong, S., Hou, S., Zheng, Z., Zhou, J., and Bao, G. (2010). Coating optimization of superparamagnetic iron oxide nanoparticles for high T2 relaxivity. Nano Lett. 10, 4607–4613.
Valberg, P.A., and Feldman, H.A. (1987). Magnetic particle motions within living cells — physical theory and techniques. Biophys. J. 52, 551–569.
Wang, J. (2005). Nanomaterial-based amplified transduction of biomolecular interactions. Small 1, 1036–1043.
Wang, N., Butler, J.P., and Ingber, D.E. (1993). Mechanotransduction across the cell-surface and through the cytoskeleton. Science 260, 1124–1127.
Weissleder, R., Moore, A., Mahmood, U., Bhorade, R., Benveniste, H., Chiocca, E.A., and Basilion, J.P. (2000). In vivo magnetic resonance imaging of transgene expression. Nat. Med. 6, 351–354.
Wust, P., Hildebrandt, B., and Sreenivasa, G. (2002). Hyperthermia in combined treatment of cancer. Lancet Oncol. 3, 487–497.
Yi, D.K., Lee, S.S., Papaefthymiou, G.C., and Ying, J.Y. (2006). Nanoparticle architectures templated by SiO2/Fe2O3 nanocomposites. Chem. Mater. 18, 614–619.
Yoo, D., Lee, J.H., Shin, T.H., and Cheon, J. (2011). Theranostic magnetic nanoparticles. Acc. Chem. Res. 44, 863–874.
Yoo, D., Jeong, H., Preihs, C., Choi, J.S., Shin, T.H., Sessler, J.L., and Cheon, J. (2012). Double-effector nanoparticles: a synergistic approach to apoptotic hyperthermia. Angew. Chem. Int. Ed. Engl. 51, 12482–12485.
Yu, M.K., Jeong, Y.Y., Park, J., Park, S., Kim, J.W., Min, J.J., Kim, K., and Jon, S. (2008). Drug-loaded superparamagnetic iron oxide nanoparticles for combined cancer imaging and therapy in vivo. Angew. Chem. Int. Ed. Engl. 47, 5362–5365.
Zhang, Y., Kohler, N., and Zhang, M. (2002). Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake. Biomaterials 23, 1553–1561.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Lee, JH., Kim, Jw. & Cheon, J. Magnetic nanoparticles for multi-imaging and drug delivery. Mol Cells 35, 274–284 (2013). https://doi.org/10.1007/s10059-013-0103-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10059-013-0103-0